Boston Partners Novo Nordisk A S Transaction History

Boston Partners

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$58.54 - $67.94 $73.2 Million - $84.9 Million	-1,249,681 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$49.46 - $64.78 $41.4 Million - $54.2 Million	-837,124 Reduced 40.12%	1,249,681 $75.2 Million
Q4 2019 Feb 05, 2020	SELL	$49.86 - $58.26 $4.41 Million - $5.16 Million	-88,496 Reduced 4.07%	2,086,805 $121 Million
Q3 2019 Nov 20, 2019	SELL	$47.54 - $53.43 $2.89 Million - $3.25 Million	-60,831 Reduced 2.72%	2,175,301 $113 Million
Q3 2019 Nov 08, 2019	BUY	$47.54 - $53.43 $97,979 - $110,119	2,061 Added 0.09%	2,236,132 $114 Million
Q2 2019 Aug 26, 2019	SELL	$46.79 - $52.47 $8,094 - $9,077	-173 Reduced 0.01%	2,234,071 $114 Million
Q2 2019 Aug 09, 2019	SELL	$46.79 - $52.47 $1.1 Million - $1.23 Million	-23,466 Reduced 1.04%	2,234,244 $114 Million
Q1 2019 May 03, 2019	BUY	$46.36 - $52.63 $4.07 Million - $4.63 Million	87,878 Added 4.05%	2,257,710 $118 Million
Q4 2018 Feb 07, 2019	BUY	$41.54 - $47.25 $90.1 Million - $103 Million	2,169,832 New	2,169,832 $100 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

Stay updated on Boston Partners with notifications on news.